Dexmethsone

Šalis: Naujoji Zelandija

kalba: anglų

Šaltinis: Medsafe (Medicines Safety Authority)

Veiklioji medžiaga:

Dexamethasone sodium phosphate 4.4mg equivalent to dexamethasone phosphate 4.0 mg

Prieinama:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (Tarptautinis Pavadinimas):

Dexamethasone sodium phosphate 4.4 mg (equivalent to dexamethasone phosphate 4.0 mg)

Dozė:

4 mg/mL

Vaisto forma:

Solution for injection

Sudėtis:

Active: Dexamethasone sodium phosphate 4.4mg equivalent to dexamethasone phosphate 4.0 mg Excipient: Creatinine Sodium citrate Water for injection

Recepto tipas:

Prescription

Pagaminta:

Sanofi Chimie

Terapinės indikacijos:

Replacement Therapy Adrenocortical Insufficiency Dexamethasone has predominantly glucocorticoid activity and, therefore, is not a complete replacement therapy in cases of adrenocortical insufficiency. Dexamethasone should be supplemented with salt and/or a mineralocorticoid, such as deoxycorticosterone. When so supplemented, dexamethasone is indicated in the following: · Acute adrenocortical insufficiency · Addison's disease · Bilateral adrenalectomy · Relative adrenocortical insufficiency · Primary and secondary adrenocortical insufficiency Prolonged administration of adrenocortical steroids can produce dormancy of the adrenal cortex. The reduced secretory capacity gives rise to a state of relative adrenocortical insufficiency which persists for a varying length of time after therapy is discontinued. Should a patient be subjected to a sudden stress during this period of reduced secretion (for up to two years after therapy has ceased) the steroid output may not be adequate. Steroid therapy should, therefore, be reinstituted to help cope with stress such as that associated with surgery, trauma, burns or severe infections where specific antibiotic therapy is available.

Produkto santrauka:

Package - Contents - Shelf Life: Vial, glass, single dose, 5 x 1 ml type I, amber vial with grey chlorobutyl stopper - 5 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 5 x 2 ml type I, amber vial with grey chlorobutyl stopper - 10 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 10 x 1 ml type I, amber vial with grey chlorobutyl stopper - 10 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 10 x 2 ml type I, amber vial with grey chlorobutyl stopper - 20 mL - 12 months from date of manufacture stored at or below 25°C protect from light

Leidimo data:

2013-04-02